August 20, 2022


IBD Rating Upgrades: Merit Medical Systems Flashes Improved Relative Price Strength

2 min read
Merit Medical Systems (MMSI) had its Relative Strength (RS) Rating upgraded from 67 to 74...

Merit Medical Systems (MMSI) had its Relative Strength (RS) Rating upgraded from 67 to 74 Thursday — a welcome improvement, but still shy of the 80 or higher score you look for.


When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.

IBD’s unique rating identifies market leadership with a 1 (worst) to 99 (best) score. The score shows how a stock’s price behavior over the trailing 52 weeks holds up against all the other stocks in our database.

History reveals that the market’s biggest winners tend to have an RS Rating of at least 80 as they begin their largest price moves. See if Merit Medical Systems can continue to show renewed price strength and clear that threshold.

See How IBD Helps You Make More Money In Stocks

Merit Medical Systems is within a buying range after breaking past a 66.36 buy point in a cup with handle. The proper buying range is up to 5% above the initial entry. Once a stock moves above that range, it’s best to wait for it to set up another buying opportunity..

Earnings growth moved up last quarter from 24% to 31%, but the top line fell from 9% to 8%. Look for the next report on or around Apr. 29.

Merit Medical Systems holds the No. 4 rank among its peers in the Medical-Products industry group. Lantheus (LNTH) and Dexcom (DXCM) are also among the group’s highest-rated stocks.


Which Stocks Are Showing Rising Relative Strength?

Why Should You Use IBD’s Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

Find Top Stocks Near A Buy Point With IBD Leaderboard

Copyright © All rights reserved. | Newsphere by AF themes.